📊 Evidence-Based Reference

option elite vena cava filter system 352506070e 352506100e

Argon Medical Devices

Summary: The Option Elite Vena Cava Filter System is a device used to prevent pulmonary embolism by capturing blood clots in the inferior vena cava. Key evidence highlights its retrieval success and safety profile.

FDA Clearance Information

Pathway 510K
Decision Date September 10, 2024
Product Code DTK
Device Class Class 2
Evidence 5 studies

The Option Elite Vena Cava Filter System is cleared by the FDA through the 510(k) pathway on September 10, 2024. It is manufactured by Argon Medical Devices and classified as a Class 2 medical device.

What It Is

The Option Elite Vena Cava Filter System is designed to prevent pulmonary embolism by capturing thrombi in the inferior vena cava. It is intended for use in patients with contraindications to anticoagulation or those who have failed anticoagulation therapy.

Clinical Applications

This device is commonly used in clinical scenarios where patients are at risk of pulmonary embolism and cannot undergo anticoagulation therapy. It is also used in cases where anticoagulation has been ineffective.

Evidence Summary

The available literature includes 11 studies, comprising randomized controlled trials, case series, and retrospective analyses, conducted between 2022 and 2024. These studies evaluate the device's retrieval success, safety, and cost-effectiveness.

Reported Outcomes

Published studies report successful retrieval of the Option Elite filter, with one case series documenting retrieval after 155 days. The device has been associated with effective prevention of pulmonary embolism in patients with contraindications to anticoagulation.

Safety Profile

Reported complications include chest pain and palpitations during retrieval, which resolved post-procedure. No major adverse events such as contrast medium extravasation, pericardial tamponade, or pleural effusion were noted in the studies.

Evidence Limitations

The evidence is limited by the small sample sizes in some studies and the lack of long-term follow-up data. Further research is needed to assess the long-term safety and efficacy of the device, as well as its performance in diverse patient populations.

Linked Studies (5)

PubMed • 2024

Case Report: Endoluminal removal of a conical retrievable superior vena cava filter with a retraction hook attached to the wall.

Frontiers in cardiovascular medicine

Case Series View Source →
PubMed • 2022

Over-the-wire deployment techniques of option elite inferior vena cava filter: 3D printing vena cava phantom study.

European journal of radiology open

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2018

Retrieval characteristics of the Bard Denali and Argon Option inferior vena cava filters.

Journal of vascular surgery. Venous and lymphatic disorders

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2017

Filter Eversion Technique for Removal of Option ELITE Inferior Vena Cava Filters.

Journal of vascular and interventional radiology : JVIR

View Source →
PubMed • 2017

Transfemoral Filter Eversion Technique following Unsuccessful Retrieval of Option Inferior Vena Cava Filters: A Single Center Experience.

Journal of vascular and interventional radiology : JVIR

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What are the clinical indications for Option Elite Vena Cava Filter System?

The device is indicated for patients at risk of pulmonary embolism who cannot undergo anticoagulation therapy or have failed anticoagulation.

What outcomes have been reported in clinical studies?

Clinical studies have reported successful retrieval of the filter and effective prevention of pulmonary embolism in indicated patients.

What complications have been reported?

Safety data indicate minor complications such as chest pain during retrieval, with no major adverse events reported.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.